Comprehensive CMV Testing Services

Cytomegalovirus (CMV) belongs to the Herpesviridae family and is a ubiquitous DNA virus transmitted through bodily fluids. While it typically causes asymptomatic or mild infections in healthy individuals, CMV infection can lead to high morbidity and severe pathological damage in immunocompromised populations (such as organ transplant recipients and HIV patients), pregnant women, and neonates.

In biomedical basic research, antiviral drug screening, and vaccine development, CMV testing is a core tool for investigating host-virus interaction mechanisms. By accurately detecting specific CMV antibodies, antigen expression levels, or analyzing infected cell populations in research samples, researchers can objectively evaluate the infection status, viral activity, and the actual efficacy of candidate interventions in in vitro models or experimental animals.

Our Services

We have built a multidimensional CMV testing matrix ranging from serological characterization to deep proteomics, meeting the profound analytical needs of various complex research projects:

Core Targets & Biomarkers

• Antibody Profiling: We offer CMV IgG testing, IgM testing, and combined CMV serological panels to accurately map the acute/chronic immune response trajectories of the host.
• Antigens & Active Infection Indicators: For active infections, we provide the classic pp65 antigen detection alongside multiple active infection indicator analyses.
• In-Depth Functional Assessment: We offer neutralizing antibody titer determination, which directly reflects the sample's ability to block CMV from infecting host cells. We also support latent infection biomarker detection and protein expression level analysis to deeply dissect viral latency and reactivation mechanisms.

Cutting-Edge Technology Platforms

To ensure high sensitivity and resolution of data, we execute analyses relying on the following advanced platforms:

• ELISA & CLIA: Utilizing ELISA for high-throughput antibody screening, combined with Chemiluminescence Immunoassay (CLIA) to achieve ultra-high sensitivity quantification of low-concentration antibodies.
• Indirect Immunofluorescence Assay (IFA): Used for rapid in situ localization and morphological analysis of viral antigens (like pp65) in tissue sections or cell smears.
• Western Blot (WB): Highly specific verification analysis of the molecular weight of targeted CMV antibodies or antigen proteins.
• Flow Cytometry: Precisely quantifying the proportion of CMV-infected target cell populations or assessing the immune activation status of host-specific T cells.
• Liquid Chromatography-Mass Spectrometry (LC-MS): Conducting biomarker identification at the proteomic level to discover novel protein targets associated with CMV infection and host immune responses.

Our Advantages

• Seamless Multi-omics/Multi-platform Integration: Providing a one-stop research closed-loop service—from routine ELISA serological preliminary screening to flow cytometry analysis, all the way to mass spectrometry-level molecular identification.
• Strict RUO Quality Control: Employing rigorously validated standards and matched antibody pairs to effectively avoid matrix interference and cross-reactivity, ensuring highly reproducible experimental data that meets the publication standards of top-tier academic journals.
• Flexible Custom Solutions: Whether evaluating the in vitro IC50 of novel antiviral small molecules or tracking long-term immunoglobulin dynamics in experimental animals, we can customize the optimal testing panel for your specific needs.

In the research journey against the complex infection mechanisms of Cytomegalovirus, comprehensive and precise biomarker analysis is the cornerstone of making breakthroughs. We look forward to becoming your trusted drug discovery and basic research partner with our comprehensive bioanalytical platforms and rigorous scientific attitude. Contact our expert team today to customize your exclusive CMV testing plan!